ASND vs. JPM

In the year-to-date period, ASND achieves a 27.62% return, which is significantly higher than JPM's 11.66% return. Over the past 10 years, ASND has outperformed JPM with an annualized return of 26.52%, while JPM has yielded a comparatively lower 17.85% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and JPMorgan Chase & Co. (JPM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ASND Sharpe Ratio is 0.65, which is lower than the JPM Sharpe Ratio of 1.20. The chart below compares the historical Sharpe Ratios of ASND and JPM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

ASND has not paid dividends to shareholders, while JPM's dividend yield for the trailing twelve months is around 1.91%.

The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum JPM drawdown of -74.02%. Use the drawdown chart below to compare losses from any high point for ASND and JPM.

Ascendis Pharma A/S (ASND) has a higher volatility of 13.65% compared to JPMorgan Chase & Co. (JPM) at 5.15%. This indicates that ASND's price experiences larger fluctuations and is considered to be riskier than JPM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Ascendis Pharma A/S and JPMorgan Chase & Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.